BIOART
Training network for developing innovative (bio)artificial devices for treatment of kidney and liver disease
| Coordinatore | UNIVERSITEIT TWENTE
Organization address
address: DRIENERLOLAAN 5 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 3˙792˙616 € |
| EC contributo | 3˙792˙616 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-ITN |
| Funding Scheme | MC-ITN |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-12-01 - 2016-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITEIT TWENTE
Organization address
address: DRIENERLOLAAN 5 contact info |
NL (ENSCHEDE) | coordinator | 881˙010.49 |
| 2 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 484˙975.92 |
| 3 |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address
address: GEERT GROOTEPLEIN NOORD 9 contact info |
NL (NIJMEGEN) | participant | 477˙022.92 |
| 4 |
UNIVERSITAET LEIPZIG
Organization address
address: RITTERSTRASSE 26 contact info |
DE (LEIPZIG) | participant | 447˙437.76 |
| 5 |
UNIVERSITE DE TECHNOLOGIE DE COMPIEGNE
Organization address
address: RUE DU DOCTEUR SCHWEITZER CS 60319 CENTRE PIERRE GUILLAUMAT contact info |
FR (COMPIEGNE CEDEX) | participant | 367˙445.43 |
| 6 |
EXCORLAB GMBH
Organization address
address: GLANZSTOFFSTRASSE INDUSTRIECENTER contact info |
DE (OBERNBURG) | participant | 286˙201.08 |
| 7 |
UNIVERSITE PAUL SABATIER TOULOUSE III
Organization address
address: ROUTE DE NARBONNE 118 contact info |
FR (TOULOUSE CEDEX 9) | participant | 255˙948.66 |
| 8 |
UNIVERSITA DELLA CALABRIA
Organization address
address: Via Pietro Bucci 7/11 B contact info |
IT (ARCAVACATA DI RENDE) | participant | 240˙837.96 |
| 9 |
GVS S.P.A.
Organization address
address: Via Roma 50 contact info |
IT (ZOLA PREDOSA (BO)) | participant | 208˙635.24 |
| 10 |
Bionethos Innovation GmbH
Organization address
address: Krankenhausstrasse 7 contact info |
DE (Parthenstein-Klinga) | participant | 143˙100.54 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Renal and liver diseases are global public health problems, with the incidences of end-stage renal disease (ESRD) and end-stage liver disease (ESLD) rising annually. Due to the lack of donor kidneys, most of ESRD patients depend on dialysis treatment using either an artificial kidney or the peritoneal membrane. Both modes are inefficient in removing uremic waste molecules and inadequately remove excess body fluids, potassium and phosphate contributing significantly to severe patient health problems, poor life quality and high mortality (15-20% per year). The impairment of liver functions has also serious implications and it is responsible for high rates of patient morbidity and mortality. Presently, liver transplantation remains the treatment of choice for ESLD patients but it is limited by both the high costs and severe shortage of donor organs. BIOART ITN will provide state-of-the-art multidisciplinary training for a cohort of 16 young researchers in order to equip them with the skills required to make a significant impact in the treatment of kidney and liver diseases. For this, BIOART ITN will develop:
- A prototype artificial kidney devices enabling prolonged / continuous removal of uremic toxins - A prototype bioartificial kidney device that utilizes human renal epithelial cells for removal of uremic toxins. - Prototype bioreactor devices to ensure viability and functions of hepatocyte cells.
In fact, BIOART ITN will provide the European Union with specific multidisciplinary expertise in the area of (bio)artificial organs for treatment of kidney and liver diseases. This will be achieved through the training of highly educated researchers able to understand and eventually to manage all scientific, industrial and clinical aspects of these (bio)artificial organs. Fourteen individual RTD Projects will be performed and thirty five scientific training courses will be offered by the host organizations to the recruited young researchers. During four years, the re'